Hancock Whitney’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $786K | Buy |
11,383
+6,148
| +117% | +$424K | 0.02% | 474 |
|
|
2025
Q1 | $364K | Sell |
5,235
-21
| -0.4% | -$1.46K | 0.01% | 511 |
|
|
2024
Q4 | $452K | Sell |
5,256
-1,017
| -16% | -$87.5K | 0.01% | 446 |
|
|
2024
Q3 | $747K | Buy |
6,273
+300
| +5% | +$35.7K | 0.02% | 365 |
|
|
2024
Q2 | $853K | Sell |
5,973
-251
| -4% | -$35.8K | 0.03% | 332 |
|
|
2024
Q1 | $799K | Sell |
6,224
-631
| -9% | -$81K | 0.03% | 347 |
|
|
2023
Q4 | $709K | Buy |
6,855
+71
| +1% | +$7.35K | 0.03% | 373 |
|
|
2023
Q3 | $617K | Buy |
6,784
+58
| +0.9% | +$5.28K | 0.03% | 373 |
|
|
2023
Q2 | $544K | Buy |
6,726
+2,042
| +44% | +$165K | 0.02% | 425 |
|
|
2023
Q1 | $373K | Buy |
4,684
+184
| +4% | +$14.7K | 0.02% | 492 |
|
|
2022
Q4 | $305K | Sell |
4,500
-220
| -5% | -$14.9K | 0.01% | 533 |
|
|
2022
Q3 | $235K | Buy |
+4,720
| New | +$235K | 0.01% | 570 |
|
|
2022
Q2 | – | Sell |
-5,008
| Closed | -$278K | – | 664 |
|
|
2022
Q1 | $278K | Buy |
5,008
+406
| +9% | +$22.5K | 0.01% | 602 |
|
|
2021
Q4 | $258K | Buy |
+4,602
| New | +$258K | 0.01% | 618 |
|
|
2014
Q4 | – | Sell |
-9,726
| Closed | -$232K | – | 536 |
|
|
2014
Q3 | $232K | Sell |
9,726
-244
| -2% | -$5.82K | 0.01% | 464 |
|
|
2014
Q2 | $230K | Buy |
+9,970
| New | +$230K | 0.01% | 473 |
|